09.29.25 -- How To Grow CHO Cells Without Cysteine, Tyrosine Feeds

Learn how to gain precise control over one of the most common and critical forms of protein modification for therapeutic benefit and stability.

Discover how advanced transfection technology can accelerate therapeutic development. Explore faster, more flexible cell-based screening assays, including mammalian display, to optimize your research.

Stable bulk cultures, made highly uniform using transposase-mediated technologies, may be the key to expediting clone selection for many biopharmaceutical applications.

Scaling up life-saving gene-edited cell therapies means tackling production inefficiencies. Overcoming the time-consuming and risky cell washing step is crucial for clinical and commercial success.

Discover a cell line that enhances rAAV production by reducing host cell DNA encapsidation, improving safety and efficiency through genetic modifications that inhibit apoptotic DNA fragmentation.

Learn how at-line cell culture media analysis enhances mAb production by refining nutrient feed strategies, reducing toxic metabolites, and improving yields while lowering costs.

The demand for complex biologics is driving the need for intensified cell culture technologies. Perfusion using ATF has emerged as a leading solution to increase cell density and productivity.

Explore the findings of studies analyzing the performance of upstream bioprocessing with Ultimus^® film, a single-use, multi-layer film with a fluid contact layer free of Irgafos^® 168.

Choosing the right transfection reagent can be confusing. This guide explores product names, their applications, and the importance of testing beyond labeled uses.